MILTEFOSE 50 is a clinically approved oral medication containing Miltefosine, an antiparasitic agent widely used in the treatment of Visceral Leishmaniasis (Kala-azar) and Cutaneous Leishmaniasis (CL). Manufactured and marketed by Steris Pharma, this medicine has proven to be a highly effective therapy against Leishmania parasites responsible for severe parasitic infections.
Miltefosine, the active component of MILTEFOSE 50, works by disrupting the membrane structure of the parasite and inhibiting its metabolic activity, leading to parasite death. It is one of the few oral treatments available for leishmaniasis, offering a convenient alternative to traditional injectable therapies.
Uses of MILTEFOSE 50
MILTEFOSE 50 is primarily indicated for the following conditions:
Visceral Leishmaniasis (Kala-azar):
This life-threatening parasitic infection affects internal organs like the liver, spleen, and bone marrow. Miltefosine helps eliminate the parasite from the bloodstream and prevents recurrence.Cutaneous Leishmaniasis:
It is used to treat skin sores caused by Leishmania parasites transmitted by sandfly bites. MILTEFOSE 50 promotes healing of skin lesions and reduces scarring.Post Kala-azar Dermal Leishmaniasis (PKDL):
In some cases, after successful treatment of visceral leishmaniasis, patients may develop PKDL. MILTEFOSE 50 helps manage and cure these residual skin manifestations.
Benefits of MILTEFOSE 50
Oral Convenience:
Unlike traditional antileishmanial therapies that require painful injections, MILTEFOSE 50 is available in an easy-to-take capsule form.High Efficacy:
Miltefosine Capsules shows potent activity against both visceral and cutaneous forms of leishmaniasis, reducing the parasite load effectively.Improved Recovery Time:
Regular use under medical supervision helps patients experience faster relief from symptoms such as fever, weight loss, anemia, and skin lesions.Reduced Risk of Recurrence:
Continuous and complete treatment course with MILTEFOSE 50 minimizes the risk of relapse or drug resistance.Trusted Formulation:
Manufactured under strict quality standards by Steris Pharma, MILTEFOSE 50 ensures safety, reliability, and consistency in every dose.
Dosage and Administration
The dosage of MILTEFOSE 50 Capsules should be determined by a healthcare professional based on the patient’s age, weight, and severity of infection.
Typical Dosage Guidelines:
Adults: Usually, one capsule (50 mg) taken once or twice daily for 28 days, depending on medical advice.
Children (Above 12 years): Dose is adjusted according to body weight, typically 2.5 mg/kg per day.
Mode of Administration: Capsules should be swallowed whole with water after meals to minimize stomach irritation.
Important Notes:
Do not skip or discontinue treatment midway.
Always complete the prescribed course even if symptoms improve early.
Consult your doctor immediately if vomiting or diarrhea occurs frequently, as it may reduce drug absorption.
Possible Side Effects of MILTEFOSE 50
While MILTEFOSE 50 is generally well-tolerated, some patients may experience mild to moderate side effects. Most of these effects are temporary and resolve with continued use or medical supervision.
Common Side Effects:
Nausea and vomiting
Abdominal pain or diarrhea
Headache
Dizziness or fatigue
Loss of appetite
Rare but Serious Side Effects:
Elevated liver enzymes
Kidney function changes
Skin rash or allergic reaction
Precautions:
Not recommended during pregnancy as it may harm the unborn baby.
Avoid use while breastfeeding.
Use effective contraception during and for at least 5 months after treatment.
Regular monitoring of liver and kidney function is advised during therapy.
Frequently Asked Questions
1. What is MILTEFOSE 50 used for?
MILTEFOSE 50 is used for the treatment of Visceral Leishmaniasis (Kala-azar) and Cutaneous Leishmaniasis caused by Leishmania parasites.
2. How does Miltefosine work?
Miltefosine interferes with the parasite’s cell membrane and metabolism, leading to its destruction and elimination from the body.
3. Is MILTEFOSE 50 safe for children?
Yes, it can be prescribed for children above 12 years under strict medical supervision and weight-based dosage adjustments.
4. Can I take MILTEFOSE 50 during pregnancy?
No, it should not be used during pregnancy due to the potential risk of birth defects. Women must use contraception during and after treatment.
5. What should I do if I miss a dose?
Take the missed dose as soon as you remember. However, if it’s near the time of your next dose, skip it and continue your regular schedule. Do not double the dose.
6. Does MILTEFOSE 50 cause any long-term side effects?
In most cases, side effects are temporary. Long-term adverse effects are rare when the medicine is used as prescribed and monitored by a doctor.
Conclusion
Miltefosine Capsules from Steris Pharma is a revolutionary oral treatment for Leishmaniasis, offering a powerful and convenient alternative to traditional injectable therapies. Its proven efficacy, safety profile, and ease of administration make it a trusted choice among healthcare professionals for managing parasitic infections like Visceral and Cutaneous Leishmaniasis.
For the best results, always take MILTEFOSE 50 as prescribed by your healthcare provider, maintain hydration, and follow the complete treatment course.
